Balchem (BCPC) EBITDA (2010 - 2026)

Balchem (BCPC) has 17 years of EBITDA data on file, last reported at $55.6 million in Q1 2026.

• On a quarterly basis, EBITDA rose 9.04% year-over-year to $55.6 million in Q1 2026; TTM through Mar 2026 was $213.9 million, a 11.28% increase from a year earlier, with the FY2025 full-year figure at $209.3 million, up 14.44% from the prior year.
• EBITDA for Q1 2026 stood at $55.6 million, up from $52.3 million in the prior quarter.
• Over the last five years, EBITDA for BCPC reached as high as $55.6 million in Q1 2026 and fell as low as $33.3 million in Q4 2022.
• Historically, EBITDA has averaged $44.2 million across 5 years, with a median of $43.6 million in 2023.
• Across the five-year window, EBITDA soared 30.49% in 2022 and slipped 10.25% in 2023, its largest moves.
• Year by year, EBITDA stood at $33.3 million in 2022, then climbed by 15.1% to $38.3 million in 2023, then rose by 23.76% to $47.4 million in 2024, then climbed by 10.21% to $52.3 million in 2025, then gained by 6.38% to $55.6 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $55.6 million in Q1 2026, $52.3 million in Q4 2025, and $54.6 million in Q3 2025.